EFFECTS OF ACUTE ST ELEVATION MYOCARDIAL INFARCTION AND CONCOMITANT COVID-19 INFECTION ON LONG-TERM CARDIOVASCULAR EVENTS

The aim of the research was to study the impact of COVID-19 on cardiovascular endpoints development within 1 year in hospitalized patients with acute myocardial infarction (MI) with ST segment elevation (STEMI), in which this viral disease was detected during the hospital period.

Material and methods. The case histories of 179 patients who were admitted to the city clinical hospital (CCH) No. 21 in Ufa from January 2020 to December 2021 to the cardiology department were studied. The patients with STEMI were divided into 2 groups. The experimental group of patients (MI-COVID) were diagnosed with COVID-19 during hospitalization (n=20), in control group (MI-nonCOVID) the infection was not detected (n=159). The presence of COVID-19 infection was confirmed using IgM studies, as well as PCR swabs from the throat and nasopharynx. After 1 year of follow-up, cardiovascular endpoints were studied using the PROMED electronic medical data storage system.

Results. Our analysis showed a tendency towards significant unfavorable course and prognosis, as well as an increase in cardiovascular mortality in STEMI patients with COVID-19 infection in comparison with patients with STEMI without this infection.

1. Matuzov G.L., Gumerov R.M. Ensuring safety of the medical workers in emergency situations in the context of proliferation covid-19. Life safety. 2021; (9): 24-27. (In Russ)

2. Chen N. [et al.] Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507-513. (In Engl)

3. Klok F.A. [et al.] Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145-147. (In Engl)

4. Helms J. [et al.] High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020; 46(6): 1089-1098. (In Engl)

5. Zheng Y-Y. [et al.] COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5): 259-260. (In Engl)

6. Michele S. De [et al.] Forty Postmortem Examinations in COVID-19 Patients. Am J Clin Pathol. 2020. 154(6): 748-760. (In Engl)

7. Kim I-C. [et al.] COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020; 41(19): 1859. (In Engl)

8. Zagidullin N.SH., Gareeva D.F., Ishmetov V.SH., Pavlov A.V., Plotnikova M.R., Pushkareva A.E., Pavlov V.N. Renin-angiotensin-aldosterone system in new coronavirus infection 2019. Arterial hypertension. 2020; 26(3): 240-247. doi:10.18705/-2020-26-3-240-247. (In Russ)

9. Pellegrini D. [et al.] Micro-thrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. Circulation. 2021; 1031-1042. (In Engl)

10. Fardman А. [et al.] Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry. PLoS One. 2021; 16(6). (In Engl)

11. Ghasemzadeh N. [et al.] A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19. Cardiol Clin. 2022; 40(3): 321-328. (In Engl)

12. Varga Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417-1418. (In Engl)

13. Motloch L.J. [et al.] Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors. Front. Cardiovasc. Med. 2022; (7): 1-13. (In Engl)

14. Subirana I. [et al.] Interhospital Variability in Acute Coronary Syndrome Management in the ATHOS Study. Rev Esp Cardiol. 2019; 72(8). (In Engl)

15. Bangalore S. [et al.] ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med. 2020; 282(25): 2478-2480. (In Engl)

16. Solano- Lopez J. [et al.] Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak. Rev Esp Cardiol (Engl Ed). 2020; 73(12): 985-993. (In Engl)